Takara Holdings Inc 2019 Integrated Report
The report describes Takara Group's fiscal 2019 performance, including record consolidated net sales of ¥277,443 million and operating income of ¥17,804 million across its three main segments. It highlights the transfer of Takara Healthcare and certain functional-food and mushroom businesses as part of a portfolio review focused on Domestic, Overseas and Biomedical businesses. Its ESG disclosures cover greenhouse-gas, water, waste, biodiversity, food safety, diversity and governance initiatives, including 113,300 t-CO2 production-process emissions and 7.33 million m3 of group water usage. The report also details gene-therapy development and international expansion of Japanese food and beverages.
Company: Takara Holdings Inc
Sector: Manufacturing
Country: Japan
Year: 2019
Type: Integrated Report
Pages: 30
Back to company
Takara Holdings Inc
Takara Group Report
The report describes Takara Group's fiscal 2019 performance, including record consolidated net sales of ¥277,443 million and operating income of ¥17,804 million across its three main segments. It highlights the transfer of Takara Healthcare and certain functional-food and mushroom businesses as part of a portfolio review focused on Domestic, Overseas and Biomedical businesses. Its ESG disclosures cover greenhouse-gas, water, waste, biodiversity, food safety, diversity and governance initiatives, including 113,300 t-CO2 production-process emissions and 7.33 million m3 of group water usage. The report also details gene-therapy development and international expansion of Japanese food and beverages.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2019
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Employees